AtaiBeckley (ATAI) Long-Term Investments (2020 - 2025)
AtaiBeckley (ATAI) posted quarterly Long-Term Investments of $42.1 million for Q4 2024.
Analysis
AtaiBeckley (ATAI) Long-Term Investments (2020 - 2025) Analysis & Trends
AtaiBeckley's Long-Term Investments history runs 1 years deep, the most recent figure standing at $42.1 million for Q4 2024.
- Quarterly Long-Term Investments rose 59.17% year-over-year to $53.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $53.9 million (up 59.17% YoY) and the FY2024 annual result came in at $28.9 million, down 67.84% from the prior year.
- Long-Term Investments held at $53.9 million in Q3 2025 per ATAI's latest filing, from $53.9 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $89.8 million in Q4 2023 and troughed at $1.5 million in Q3 2021.
- A 5-year average of $24.8 million and a median of $16.1 million in 2021 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2023 and 2024: Long-Term Investments jumped 1229.76% in 2023, then plunged 67.84% in 2024.
- Over 5 years, Long-Term Investments stood at $16.1 million in 2021, then slumped by 58.12% to $6.8 million in 2022, then surged by 1229.76% to $89.8 million in 2023, then slumped by 67.84% to $28.9 million in 2024, then surged by 86.75% to $53.9 million in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods registered $53.9 million, $53.9 million, and $23.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -4.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1.77 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 372.10 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | 53.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 53.95 Mn |
| Jun 30, 2025 | 53.95 Mn |
| Mar 31, 2025 | 42.08 Mn |
| Dec 31, 2024 | 42.08 Mn |
| Dec 31, 2024 | 42.08 Mn |
| Sep 30, 2024 | 45.23 Mn |
| Jun 30, 2024 | 61.14 Mn |
| Mar 31, 2024 | 90.21 Mn |
| Dec 31, 2023 | 89.83 Mn |
| Sep 30, 2023 | 71.51 Mn |
| Jun 30, 2023 | 3.99 Mn |
| Mar 31, 2023 | 5.85 Mn |
| Dec 31, 2022 | 6.76 Mn |
| Sep 30, 2022 | 8.50 Mn |
| Jun 30, 2022 | 9.23 Mn |
| Mar 31, 2022 | 10.59 Mn |
| Dec 31, 2021 | 16.13 Mn |
| Sep 30, 2021 | 15.09 Mn |
| Jun 30, 2021 | 19.78 Mn |
| Dec 31, 2020 | 8.04 Mn |